Halberd Akcija

Halberd EBITDA

Vrijednost EBITDA (Заработак пре камата, пореза, амортизације и отписивања) od Halberd (HALB) na dan 12. авг 2026. je -18.665,00 USD. Prethodne godine, EBITDA (Заработак пре камата, пореза, амортизације и отписивања) je bio -75.050,00 USD — promjena od -75,13% (viši).

EBITDA

-18.665,00USD

YoY

-75,13%

Zadnja ažuriranja:

EBITDA (Заработак пре камата, пореза, амортизације и отписивања) od Halberd je 2026 -18.665,00 USD. EBITDA (Заработак пре камата, пореза, амортизације и отписивања) od Halberd je bio 2025 -75.050,00 USD. Pad je time -75,13% viši u odnosu na prethodnu godinu.
Access this data via the Eulerpool API

Halberd Анализа акција

Šta radi Halberd? The Halberd Corp is an American company founded in 1987 and based in New York. It is a high-tech company focused on the development of medical technologies. Since its inception, the company has developed numerous innovative products and technologies that are used worldwide. A significant portion of Halberd Corp's business model focuses on providing medical products and solutions for various diseases. The main divisions of the company are biotechnology and pharmaceuticals, medical respiratory protection, medical technology, and the development of antibodies and diagnostics. Some of the most well-known products of Halberd Corp are the Medical Respiratory Masks, which were of great importance during the COVID-19 pandemic. These masks were developed and distributed worldwide by the company with innovative technology and the highest quality standards. The company has also developed various medical devices such as infusion pumps, blood pressure monitors, and various diagnostic devices that have been used by hospitals and care facilities. Another important business area of Halberd Corp is biotechnology and pharmaceuticals. In this field, the company specializes in developing new drugs and therapies for various diseases. The company has developed a range of proprietary medications that are used in the treatment of various diseases. Halberd Corp is also known for its development of antibodies and diagnostics and offers corresponding test kits. In recent years, Halberd Corp has formed numerous partnerships with other companies and institutions to bring its innovations to the market and market them. The company is also known for its successful joint ventures with other companies in the healthcare sector. Overall, Halberd Corp is an innovative company focused on medical technologies. With its presence in various areas of the healthcare industry, the company is able to develop new products and solutions that have the potential to improve and save lives. Halberd je jedna od najpopularnijih kompanija na Eulerpool.

Često postavljena pitanja o akciji Halberd

EBITDA (Заработак пре камата, пореза, амортизације и отписивања) kompanije Halberd iznosi -18.665,00 USD u 2026. godini.

EBITDA (Заработак пре камата, пореза, амортизације и отписивања) od Halberd se promijenio sa -75.050,00 USD na -18.665,00 USD, što predstavlja promjenu od -75,13%. Vrijednost je viši nego prethodne godine.

Na Eulerpool-u možete pronaći potpuni historijski razvoj EBITDA (Заработак пре камата, пореза, амортизације и отписивања) Halberd od 2006. — sa godišnjim vrijednostima, grafikonima i detaljnom analizom.

EBITDA мери оперативну перформансу пре утицаја финансијске структуре, окружења пореза и не-готовинских отписивања.

EBITDA = EBIT + Амортизација и отписивање

EBITDA (Заработак пре камата, пореза, амортизације и отписивања)'s USD je ključan faktor za investitore. Promene u ovoj metrici mogu signalizirati poboljšane ili pogoršane fundamentalne faktore, direktno utiču na cenu akcije. Na Eulopoolu, možete pratiti EBITDA (Заработак пре камата, пореза, амортизације и отписивања)'s Halberd istorijski i u realnom vremenu.

Access this data via the Eulerpool API

Извештај о добити и губитку — Halberd

Sve ključne metrike — Halberd

Раст